+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Consumer Health in Israel

  • ID: 2595579
  • Report
  • November 2020
  • Region: Israel
  • 110 pages
  • Euromonitor International
Consumer health is expected to see slower current value growth in 2020 than was seen the previous year. One of the factors dictating growth in this year is expected to be COVID-19. As news about the virus emerged in the country, consumers began panic-buying at the start of quarter two of 2020, stockpiling certain consumer health products, such as analgesics, cough, cold and allergy (hay fever) remedies, immunity-boosting vitamins and dietary supplements and eye care, for fear of shortages.

The publisher's Consumer Health in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
EXECUTIVE SUMMARY
  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?
MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 1 Research Sources
KEY DATA FINDINGS

2020 IMPACT
  • Consumers stockpile analgesics, but are likely to finish stockpiles first thereby limiting growth overall in 2020
  • E-commerce sales grow due to COVID-19, while stressful and busy lifestyles drive growth of analgesics
  • Teva Pharmaceutical Industries continues to lead, while consumers stay loyal to GSK’s ibuprofen brands and private label continues to gain share in 2020
RECOVERY AND OPPORTUNITIES
  • Steady growth expected thanks to being a familiar category in households
  • Consumers continue to switch from system analgesics to topical formats in order to avoid unnecessary chemicals
  • New chemists/pharmacies retail outlets likely to stimulate price competition and growth
CATEGORY DATA
  • Table 11 Sales of Analgesics by Category: Value 2015-2020
  • Table 12 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 13 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 14 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 15 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased
  • Growth limited by the lack of flu cases, mainly as a result of COVID-19
  • Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020
RECOVERY AND OPPORTUNITIES
  • Stable growth forecast, driven by combination products - cough, cold and allergy (hay fever) remedies
  • Growth in nasal sprays as saltwater sprays largely used for children
  • Growth to slow as winters return to more normal patterns
CATEGORY DATA
  • Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Growth negated thanks to travel ban and consumers preparing meals at home
  • Strong competition from medical devices
  • GSK Consumer Healthcare increases its lead but face increasing competition from medical devices, prescription medication, and lifestyle changes
RECOVERY AND OPPORTUNITIES
  • Rebound expected from 2021 but trends in consumer eating habits will have conflicting effects on digestive remedies
  • Indigestion and heartburn remedies set to continue suffering from a shift to prescription medication
  • Ageing population supports growth
CATEGORY DATA
  • Table 23 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 24 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 25 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 26 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 27 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Opposing forces impact dermatologicals as a result of the pandemic in 2020
  • Strong competition from medical devices and cosmetic products limits growth of dermatologicals
  • Perrigo Israel Pharmaceuticals maintains its lead, while Bayer Israel gains share in 2020
RECOVERY AND OPPORTUNITIES
  • High birth rate set to contribute to growth over the forecast period
  • Medicated shampoos boosted by the entry of Head & Shoulders
  • Hair loss treatments expensive resulting in a shift to lower-priced cosmetic products
CATEGORY DATA
  • Table 29 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 30 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 31 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 32 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 34 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Several factors related to COVID-19 contribute to growth in 2020
  • Increasing growth as regulation of smokeless tobacco and e-vapour products rise
  • Nicotinell – virtually the only brand present
RECOVERY AND OPPORTUNITIES
  • The shrinking potential user base set to limit growth
  • HMO’s offer alternatives to NRT smoking cessation aids
  • NRT lozenges unpopular
CATEGORY INDICATORS
  • Table 36 Number of Smokers by Gender 2015-2020
CATEGORY DATA
  • Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
  • Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
  • Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
  • Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • More consumers have sleep problems due to COVID-19 and seek help
  • Consumers increasingly consult their doctors in order to avoid the potential side effects of sleep aids
  • Neopharm Import (Israel) 1966 continues to lead but faces increasing competition, and private label continues to lose share in 2020
RECOVERY AND OPPORTUNITIES
  • Sleep aids likely to grow as consumers more willing to use medication for insomnia but countered by consumers’ suspicion of side-effects
  • Hectic lifestyles encourage more consumers to turn to sleep aids
  • Herbal/traditional sleep aids increasingly popular as consumers seek natural remedies
CATEGORY DATA
  • Table 43 Sales of Sleep Aids: Value 2015-2020
  • Table 44 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 45 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 46 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 47 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 48 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • More time spent on screens for work and entertainment contributes to growth while personal hygiene decreases incidence of eye infections in 2020
  • Shift to higher-priced products
  • Lapidot Medical Import and Marketing extends its lead
RECOVERY AND OPPORTUNITIES
  • Increasing screen use and air-conditioned offices leads to ongoing demand for eye care
  • Manufacturers shift to medical devices to gain greater flexibility
  • Private label relatively strong in allergy eye care
CATEGORY DATA
  • Table 49 Sales of Eye Care by Category: Value 2015-2020
  • Table 50 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 51 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 52 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 53 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Slower growth rate from COVID-19 as consumers spend more time at home
  • Growing variety of printed plasters
  • Chemipal extends its lead but strong growth for private label threatens its position
RECOVERY AND OPPORTUNITIES
  • Growth expected to be driven by the health and wellness trend
  • Little innovation in wound care leads to low brand loyalty
  • Consumers seeking value-for-money likely to support private label
CATEGORY DATA
  • Table 55 Sales of Wound Care by Category: Value 2015-2020
  • Table 56 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 57 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 58 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 59 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 60 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Vitamin C sees growth thanks to the pandemic, followed by vitamin D
  • E-commerce boosted by the pandemic in 2020
  • Ta'am Teva-Altman General Partnership maintains its lead and Ambrosia Ltd Solgar Israel loses share
RECOVERY AND OPPORTUNITIES
  • Solid growth as some consumers maintain the habit of taking vitamins
  • Innovation increasingly focuses on vitamin absorption to position vitamins as effective products
  • The rising popularity of sports activities likely to drive growth of vitamins
CATEGORY DATA
  • Table 61 Sales of Vitamins by Category: Value 2015-2020
  • Table 62 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 63 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 64 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 65 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 66 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 67 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Immune boosting dietary supplements ensures stronger growth in 2020 with some shortages due to stockpiling
  • Shift to e-commerce intensifies as consumers avoid shops due to COVID-19
  • Ta'am Teva-Altman General Partnership maintains its lead, while Ambrosia Ltd Solgar Israel remains in second place despite losing share
RECOVERY AND OPPORTUNITIES
  • Strong growth for dietary supplements, especially probiotics over forecast period
  • Dietary supplements expected to be driven by successive trends over forecast period
  • Growing demand for combination dietary supplements
CATEGORY DATA
  • Table 68 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 69 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 70 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 71 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 72 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 73 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Weight loss supplements drives growth due to increased snacking during lockdown in 2020
  • Herbalife International of Israel (1990) makes dramatic progress, while Oriental Secrets loses share due to the dramatic declines in slimming teas in 2020
  • Direct selling retains majority share and e-commerce gains value share in 2020
RECOVERY AND OPPORTUNITIES
  • Supplement nutrition drinks expected to continue to drive growth
  • Alternative diets to remain popular
  • Meal replacement in decline due to growing awareness of nutrition
CATEGORY DATA
  • Table 75 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 76 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 77 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 78 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 79 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Active lifestyles contribute to growth, with a move seen to e-commerce
  • Sports nutrition becomes mainstream, continuing to extend its reach from just professional sports people in 2020
  • Meditrend continues to lead in 2020, while Setty Sport continues to lose share following bribery scandal
RECOVERY AND OPPORTUNITIES
  • Rapid growth thanks to growing awareness of the importance of protein consumption over the forecast period
  • Availability set to improve
  • Local regulation hinders stronger growth over the forecast period
CATEGORY DATA
  • Table 81 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 82 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 83 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 84 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 85 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 86 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Growth rate relatively stable despite COVID-19
  • A holistic approach to health contributes to growth in 2020
  • Ta'am Teva-Altman General Partnership retains its lead and private label extends its share in 2020
RECOVERY AND OPPORTUNITIES
  • Herbal/traditional paediatric dietary supplements likely to drive growth as parents seek to ensure balanced nutrition for their children
  • Herbal/traditional sleep aids increasingly popular due to concerns about potential side effects of standard versions
  • Herbal/traditional topical analgesics likely to decline as consumers do not see the need for more natural products
CATEGORY DATA
  • Table 87 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 88 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 89 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 90 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 91 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Growth somewhat curtailed in 2020 as data regarding the manifestation of COVID-19 in children becomes available
  • Paediatric analgesics increasingly used to treat children’s fevers
  • Teva Pharmaceutical Industries maintains its lead and Ta'am Teva-Altman General Partnership retains its second place, while private label increases its share in 2020
RECOVERY AND OPPORTUNITIES
  • Slower but still solid growth expected for the forecast period
  • Hectic lifestyles expected to encourage parents to provide paediatric vitamins and dietary supplements to their children
  • Shift to more natural nasal sprays in paediatric cough/cold remedies which are gentler on children’s skin
CATEGORY DATA
  • Table 93 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 94 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 95 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Note: Product cover images may vary from those shown
Adroll
adroll